The House Energy and Commerce Health Subcommittee today approved legislation that would prohibit Medicare and private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance. Some health insurance contracts prevent pharmacists from informing patients when the cash price for their prescription costs less than their insurance cost-sharing arrangement unless the individual asks. The subcommittee also approved a bill that would allow the Centers for Medicare & Medicaid Services to provide certain drug rebate information to the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment Advisory Commission to inform their recommendations on drug-related issues.

Related News Articles

Headline
Senate Health, Education, Labor and Pensions Committee leaders today released a manager’s amendment to the Lower Health Care Costs Act of 2019 (S.1895) –…
Headline
The AHA today submitted comments on the revised version of the Lower Health Care Costs Act (S. 1895), legislation to prevent surprise medical bills, reduce…
Headline
The House Ways and Means Committee today passed the Economic Mobility Act (H.R. 3300), tax legislation that includes an AHA-supported provision to repeal a…
Headline
The House of Representatives yesterday voted 226-203 to approve a package of four appropriations bills for fiscal year 2020, which includes legislation that…
Headline
Sens. Lamar Alexander, R-Tenn., and Patty Murray, D-Wash., today introduced the Lower Health Care Costs Act (S.1895), legislation to prevent surprise medical…
Headline
The House of Representatives last night passed legislation (H.R. 3253) that includes an AHA-supported provision that would extend the Community Mental Health…